See also this year's filing and all EDGAR filings for this company.
PDF Report 0001017491_2014_Seelos_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001017491, Seelos Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 22,264,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 955,000 |
| 3 | remainder_Assets | 91,000 |
| 4 | LiabilitiesCurrent | 11,760,000 |
| 5 | LiabilitiesNoncurrent | 91,000 |
| 6 | remainder_Liabilities | 487,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,554,000 |
| 9 | ResearchAndDevelopmentExpense | 5,123,000 |
| 10 | remainder_Expenses | 1,201,000 |
| 11 | remainder_Revenues | 2,511,000 |
| 12 | remainder_NetIncome | 429,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,310,000 |
| 1 | Liabilities | 12,338,000 |
| 2 | Expenses | 19,878,000 |
| 3 | Revenues | 2,511,000 |
| 4 | StockholdersEquity | 10,972,000 |
| 5 | NetIncome | -16,938,000 |
| 6 | ComprehensiveNetIncome | -16,938,000 |
| 7 | BaseVar | 29,233,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.392 |
| 9 | EconomicCapitalRatio | 1.78 |